BRAND_ANALYSIS#ILLUMINAHEALTH & PHARMA#5 OF 26 IN HEALTH & PHARMAINTERESTING
Illumina
· Public · Updated 04 Oct 2026 09:24 UTC
#133 of 1208 overall by tension · #5 of 26 in Health & Pharma
21Interesting
The Silent Giant
Analysis
The genomics sequencer that turned science fiction into nasdaq reality. C=45, B=66, and +28.04% stock surge in 30 days signal a company riding the biotech wave before the inevitable correction. Sentiment at 0.50 is cautious because CRISPR fears remain.
IN THE NEWS (36 articles this week)
Illumina, Inc. (ILMN) Stock Price, News, Quote & History - Yahoo! Finance Canada
The Benchmark Matters: Evaluating TruPath Genome Beyond Individual Loci - Illumina
Where Will Illumina Stock Be in 5 Years If Its AI Bet Pays Off? - The Motley Fool